- Home
- SNCR vs ETON Comparison
SNCR vs ETON Comparison
Compare SNCR & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- ETON
- Stock Information
- Founded
- SNCR 2000
- ETON 2017
- Country
- SNCR United States
- ETON United States
- Employees
- SNCR N/A
- ETON N/A
- Industry
- SNCR EDP Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- SNCR Technology
- ETON Health Care
- Exchange
- SNCR Nasdaq
- ETON Nasdaq
- Market Cap
- SNCR 137.5M
- ETON 199.5M
- IPO Year
- SNCR 2006
- ETON 2018
- Fundamental
- Price
- SNCR $11.25
- ETON $8.77
- Analyst Decision
- SNCR
- ETON Strong Buy
- Analyst Count
- SNCR 0
- ETON 3
- Target Price
- SNCR N/A
- ETON $12.00
- AVG Volume (30 Days)
- SNCR 81.2K
- ETON 214.1K
- Earning Date
- SNCR 11-12-2024
- ETON 11-11-2024
- Dividend Yield
- SNCR N/A
- ETON N/A
- EPS Growth
- SNCR N/A
- ETON N/A
- EPS
- SNCR N/A
- ETON N/A
- Revenue
- SNCR $167,615,000.00
- ETON $31,381,000.00
- Revenue This Year
- SNCR $7.76
- ETON $19.61
- Revenue Next Year
- SNCR $5.83
- ETON $35.39
- P/E Ratio
- SNCR N/A
- ETON N/A
- Revenue Growth
- SNCR 33.39
- ETON 8.14
- 52 Week Low
- SNCR $2.70
- ETON $3.03
- 52 Week High
- SNCR $15.46
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- SNCR 43.11
- ETON 76.07
- Support Level
- SNCR $10.45
- ETON $7.58
- Resistance Level
- SNCR $11.44
- ETON $8.66
- Average True Range (ATR)
- SNCR 0.57
- ETON 0.42
- MACD
- SNCR -0.06
- ETON -0.07
- Stochastic Oscillator
- SNCR 31.58
- ETON 91.49
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.